(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MELTAC-RX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

MELTAC-RX

ST13

US500000079166699

Class

9

Filing

79166699

Registration

4911395

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

36

Latest update

05/04/2025

Trademark type

Word

Nice classes

9

Filing date

03/02/2015

Registration date

03/08/2016

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/23/2022

Last transaction

05/04/2025

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

4

Owner type

03

Owner location

JP

Examiner

KING,CHRISTINA B

Law office

L90

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

M. C. (pessoa física)

Representatives

Perla M. Kuhn Fox Rothschild LLP

Technical classification

Nice Classes

Class 9

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

Computer hardware and software for use in monitoring and controlling operation status of nuclear power plants; programmable logic controllers; electric control panels; CRT displays; LCD displays; PDP monitors; LED displays; and telecommunications and data networking hardwaredevices for transporting and aggregating voicedatavideo communications across multiple network infrastructures and communications protocols all for use in monitoring and controlling operation status of nuclear power plants

Publications

History of USPTO decisions and trademark events.

36 publications found

Further Decision Processed by IB

05/03/2025

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

03/17/2025

INNA

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE

03/17/2025

XXCR

GENERIC MADRID TRANSACTION CREATED

03/17/2025

RNWL

INTERNATIONAL REGISTRATION RENEWED

02/28/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

02/07/2025

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

05/23/2023

RFNT

REFUSAL PROCESSED BY IB

12/27/2022

NREP

NEW REPRESENTATIVE AT IB RECEIVED

10/07/2022

C71T

CANCELLED SECTION 71

09/23/2022

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

03/08/2021

NREP

NEW REPRESENTATIVE AT IB RECEIVED

10/02/2020

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

07/02/2016

FICS

FINAL DISPOSITION NOTICE SENT TO IB

06/09/2016

FIMP

FINAL DISPOSITION PROCESSED

06/09/2016

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

06/08/2016

R.PR

REGISTERED-PRINCIPAL REGISTER

03/08/2016

GPNX

NOTIFICATION PROCESSED BY IB

01/04/2016

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/22/2015

PUBO

PUBLISHED FOR OPPOSITION

12/22/2015

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

12/16/2015

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

12/16/2015

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/02/2015

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/22/2015

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/22/2015

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/21/2015

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/21/2015

RFNP

REFUSAL PROCESSED BY IB

07/11/2015

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

06/23/2015

RFRR

REFUSAL PROCESSED BY MPU

06/23/2015

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

06/21/2015

CNRT

NON-FINAL ACTION WRITTEN

06/20/2015

MAFR

APPLICATION FILING RECEIPT MAILED

06/16/2015

DOCK

ASSIGNED TO EXAMINER

06/12/2015

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/12/2015

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

06/11/2015

Continuous trademark protection

Get notified about every new filing that threatens MELTAC-RX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.